A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...
To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...
The inaugural competition surprisingly awarded two $100,000 grand prizes to address challenges in defining robust benchmarks for complex biology.
A collaborative effort by the Formosa-Jordan lab from the Max Planck Institute for Plant Breeding Research in Cologne, ...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback